{"id":138333,"date":"2025-07-05T06:41:57","date_gmt":"2025-07-04T22:41:57","guid":{"rendered":"http:\/\/www.gocpmall.com\/?p=138333"},"modified":"2025-07-05T06:41:57","modified_gmt":"2025-07-04T22:41:57","slug":"%e8%82%a1%e5%b8%82%e5%bf%85%e8%af%bb%ef%bc%9a%e5%b9%bf%e7%94%9f%e5%a0%82%ef%bc%88300436%ef%bc%897%e6%9c%882%e6%97%a5%e8%91%a3%e7%a7%98%e6%9c%89%e6%9c%80%e6%96%b0%e5%9b%9e%e5%a4%8d_%e8%b4%a2%e5%af%8c","status":"publish","type":"post","link":"https:\/\/www.gocpmall.com\/?p=138333","title":{"rendered":"\u80a1\u5e02\u5fc5\u8bfb\uff1a\u5e7f\u751f\u5802\uff08300436\uff097\u67082\u65e5\u8463\u79d8\u6709\u6700\u65b0\u56de\u590d_\u8d22\u5bcc\u53f7_\u4e1c\u65b9\u8d22\u5bcc\u7f51"},"content":{"rendered":"

\"news
截至2025年7月2日收盘，广生堂(300436)报收于35.65元，下跌2.7%，换手率4.78%，成交量6.53万手，成交额2.35亿元。 董秘最新回复 投资者： 2025年6月28日 —GST-HG141（奈瑞可韦）三期临床试验启动会在重庆隆重举行。由福建广生中霖生物科技有限公司（以下简称“广生中霖”）主办，全国数十家临床研究中心的专家及研究人员线上线下共同参与，GST-HG141（奈瑞可韦）三期临床试验正式进入实施阶段，标志着该药物向上市迈出关键一步，有望成为全球首个同类机制乙肝治疗药物（First in class项目），请问该药有没有优先审评审批进程 董秘： 尊敬的投资者，您好！GST-HG141（奈瑞可韦）已于2024年12月纳入国家突破性治疗品种名单。创新药因为研发周期长，投入大，风险高，容易受到技术、审批、政策等多方面因素的影响，临床研究存在结果不及预期甚至临床研究失败的风险，后续能否获得批准存在不确定性，敬请注意投资风险。 当日关注点交易信息汇总：7月2日，广生堂主力资金净流出2423.1万元，游资资金净流出844.27万元，而散户资金则净流入3267.36万元。交易信息汇总7月2日，广生堂的资金流向情况如下：主力资金净流出2423.1万元；游资资金净流出844.27万元；散户资金净流入3267.36万元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 追加内容 本文作者可以追加内容哦 !
阅读更多（Read More）<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

截至2025年7月2日收& […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-138333","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts\/138333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=138333"}],"version-history":[{"count":0,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts\/138333\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=138333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=138333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=138333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}